Pulmonary Hypertension

September 15, 2015November 5, 2015

phaware Organization Launches With Focus On High-Tech PH Education

A new non-profit organization and website has been launched to help support people who suffer from pulmonary hypertension (PH) and chronic thromboembolic pulmonary hypertension (CTEPH). The phaware Global Association (phaware) will collaborate with leaders in ... Read more

September 11, 2015November 5, 2015

Novel C-Pulse Technology Could Help Treat Pulmonary Arterial Hypertension

News, Pulmonary Hypertension

Sunshine Heart, Inc., a company that develops medical devices to aid in cardiac muscle related complications, recently announced a new collaboration with Dr. Mark Slaughter and the University of Louisville to study ... Read more

September 3, 2015November 5, 2015

Clinicians Find That Moderate Exercise Training is Beneficial for Pulmonary Hypertension Patients

News, Pulmonary Hypertension

A recent study published in Circulation: Heart Failure journal entitled “Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: A Systematic Review and Meta-Analysis,” clinicians revealed that it is ... Read more

August 31, 2015November 5, 2015

Gilead Sciences Publishes Data From AMBITION Study of Treatment With Letairis and Tadalafil in Pulmonary Arterial Hypertension

News, Pulmonary Hypertension

Gilead Sciences, Inc., a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical needs, recently announced detailed data from its AMBITION randomized, double-blind, multicenter ... Read more

August 28, 2015November 5, 2015

Catheter-Directed, Low-Dose Fibrinolysis Safe, Effective for PE

News, Pulmonary Hypertension

In a recent study entitled “A prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, low Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism,” published in JACC Cardiovascular Intervention, researchers reported ... Read more

August 27, 2015November 5, 2015

Researchers Assess Best Exercise Protocol for Pulmonary Hypertension Patients

News, Pulmonary Hypertension

An award of $465,000 from the National Institutes of Health was recently granted to a physical therapy researcher from the IU School of Health and Rehabilitation Services at Indiana University-Purdue University ... Read more

August 27, 2015November 5, 2015

Actelion to Present Data on Selexipag (Uptravi) and Macitentan (Opsumit) for PAH at Upcoming European Conference

News, Pulmonary Hypertension

Actelion Ltd, a leading biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases with significant unmet medical needs, recently announced that the results of its ... Read more

August 25, 2015November 5, 2015

Daiichi Sankyo Launches Worldwide Studies To Gauge Use of LIXIANA For Treating Pulmonary Embolism, Other Diseases

News, Pulmonary Hypertension

Daiichi Sankyo Europe GmbH announced enrollment of the first patient in the ETNA-AF-Europe (Edoxaban Treatment in routine clinical prActice – Atrial Fibrillation – Europe) registry, and the official launch of the ETNA-VTE-Europe (Edoxaban Treatment in routine clinical prActice – Venous ThromboEmbolism – Europe) ... Read more

August 24, 2015November 5, 2015

New Method of Evaluating Right Ventricular Function Predicts Pulmonary Arterial Hypertension Outcome in Patients

News, Pulmonary Hypertension

People with pulmonary hypertension have high blood pressure in the lung arteries rather than in regular circulation. The disease can be caused by several other conditions and diseases, including connective tissue ... Read more

August 24, 2015November 5, 2015

Mechanism of Resveratrol Action in PAH Identified by Study

News, Pulmonary Hypertension

Researchers at Peking Union Medical College Hospital in Beijing discovered a novel pathway of cell cycle regulation in pulmonary arterial hypertension (PAH) disease progression. A collection of experiments described in ... Read more